City

Jeddah (1)

Miami (1)

Riyadh (1)

Zurich (1)

Condition

Fistulizing Crohn's Disease (3)

Crohn Disease (1)

Crohn's Disease (1)

Inflammatory Bowel Diseases (1)

Stem Cells (1)

Ulcerative Colitis (1)

Overall Status

Completed (2)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Delenex Therapeutics AG (1)

Hikma Pharmaceuticals LLC (1)

Joshua M Hare (1)

Collaborator

Intervention

allogeneic bone marrow derived human mesenchymal stem cells (hmscs) (1)

dlx105 (1)

infliximab (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

fistulizing crohn's disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Remsima® in Treatment of Inflammatory Bowel Diseases Among Saudi

Completed

Inflammatory Bowel Diseases
+3 more

Infliximab

Jeddah, Saudi Arabia
+3 more

Feb 22, 2021

Crohn's Disease, Fistulizing Crohn's Disease, Stem Cells Trial in Miami (Allogeneic Bone Marrow derived Human Mesenchymal Stem

Withdrawn

Crohn's Disease
+2 more

Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)

Miami, Florida

Univeristy of Miami Miller School of Medicine

Jun 20, 2019

Fistulizing Crohn's Disease Trial in Zürich (DLX105, Placebo)

Completed

Fistulizing Crohn's Disease

DLX105
Placebo

Zürich, Switzerland

University Hospital

Feb 3, 2014